Not so with allergy medicines, which enjoy a significant afterlife as over-the-counter brands. Claritin from ... one big antihistamine--Allegra from Sanofi-Aventis --had not been participating ...

An experimental COPD drug from Sanofi and Regeneron showed mixed results in a pair of studies, sending the companies' shares ...

company makes two dozen consumer health care products, including Icy Hot pain ... saying the U.S. launch of Sanofi-Aventis brands, generally unknown here, would be prohibitively costly.

Sanofi-aventis also announced today that ... The Company's portfolio of products includes well-recognized brands such as Icy Hot(R), Gold Bond(R), Selsun Blue(R), ACT(R), Cortizone-10(R) and ...

Sanofi faces setbacks after itepekimab’s Phase 3 COPD failure, removing a key growth prospect and highlighting reliance on ...

They’ve got products that are either No. 1 or a ... saying the U.S. launch of Sanofi-Aventis brands, generally unknown here, would be prohibitively costly. Down the road, Sanofi-Aventis foresees ...

Giants like Sanofi-Aventis and GlaxoSmithKline are not ... That recently started division sells off-patent brand-name Pfizer products like the antidepressant Zoloft. It also markets generic ...

Sanofi-Aventis U.S. was hit with a consumer class action Thursday in California Northern District Court over the company's hydrocortisone-based products. The complaint, which was brought by ...

Sanofi-Aventis Korea is bringing Cenovis ... The Seoul-based company said Tuesday that it plans to release 10 products under the Cenovis brand out of its total 600-plus lineup in consideration ...

Sanofi and Regeneron said that drug candidate Itepekimab didn’t meet primary endpoint in a phase three study, although a ...

profitable double-digit growth and market-leading brand in health & wellness to Sanofi’s CHC U.S. portfolio Addition of Qunol’s CoQ10 and Turmeric products strengthens Sanofi’s CHC Vitamin ...